About Leuko
A focused team taking on a major medical need.
Improving quality of life and outcomes for cancer patients and others at risk of severe neutropenia, through the first noninvasive white blood cell monitor.
Executive Team
-
Carlos Castro Gonzalez, PhD
Chief Executive Officer
15+ yrs biomedical engineer & medtech innovator; led customer discovery, strategic partnerships, fundraising, and go-to-market; MIT-trained; prior medtech startup experience.
LinkedIn → -
Ian Butterworth, MSc
Chief Technology Officer
15+ yrs building medical device hardware, electronics & software into commercial-grade products; MIT research engineer; prior medtech startup experience.
LinkedIn → -
Aurelien Bourquard, PhD
Chief Data Scientist
15+ yrs in AI for biomedical imaging; built & deployed production-grade algorithms for medical devices at scale; EPFL & MIT trained; cutting edge peer-reviewed publication record.
LinkedIn → -
Alvaro Sanchez-Ferro, MD, PhD
Chief Medical Officer
20+ yrs clinical practice, led clinical study design and execution for regulatory and clinical adoption of medical devices; MIT-trained; prior medtech startup experience.
LinkedIn →
Product Development
-
Alberto Pablo Trinidad
Machine Learning Engineer
LinkedIn → -
Michael Wolf
Principal Product Engineer
LinkedIn → -
Ganimete Lamaj
Human Factors Engineer & Quality Manager
LinkedIn → -
Ryan Benasutti
Senior Software Engineer
LinkedIn → -
Jose Antonio Pelaez Escobar
Computer Vision and Machine Learning Engineer
LinkedIn →
Board of Directors
-
Amy Salzhauer
Good Growth Capital
LinkedIn → -
Lorenzo Pradella
HTH VC
LinkedIn → -
Paul Hartung
Independent Board Member
LinkedIn →
Board of Advisors
-
Ephraim Hochberg, MD
Key opinion leader in hematology.
LinkedIn → -
Javier Cortes, MD
Key opinion leader in oncology.
LinkedIn → -
Janice Hogan
30+ years in regulatory strategy & approval of breakthrough devices.
LinkedIn → -
Marta Zanchi
Go-to-market execution and healthcare operations.
LinkedIn → -
Peter Soltani
Commercialization and strategic partnerships.
LinkedIn →
Awards
-
MIT delta v Accelerator
-
"Impacto Salud" Award, Ashoka
-
"Innovatech" Award, UPM
-
1st Place Winner $200K Competition, M2D2 · 2018
-
MassConnect
-
MIT $100K Entrepreneurship Competition
-
Philips Innovation Award
-
1st Place Diamond Prize Winner, Pulse@MassChallenge HealthTech · 2018
-
Rice Brown School of Engineering Tech Innovation Prize
-
"Patient–Physician Relations" Winner, Sanitas
Our Origin Story
Leuko spun out from the Massachusetts Institute of Technology and the Madrid–MIT M+Visión Consortium. The founders were research fellows in a biomedical technology innovation initiative who felt compelled to solve a big unmet medical need for cancer patients undergoing treatment.